The trimebutine drug market is anticipated to grow at a significant CAGR of 5.3% during the forecast period (2022-2028). Trimebutine drug is used for the treatment of a gastrointestinal condition known as irritable bowel syndrome. This condition affects the functioning of the gastrointestinal tract of the body. This drug comes in a class of spasmolytic […]
